TY - VIDEO
AU - U.S. Food and Drug Administration
A1 - 
C4 - This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
C5 - Grey Literature; Opioids & Substance Use
CY - Silver Spring, MD
M1 - Web Page
PB - U.S. Food and Drug Administration (FDA)
PP - Silver Spring, MD
PY - 2022
RN - https://www.fda.gov/drugs/information-drug-class/fda-opioid-systems-modeling-effort
T1 - FDA Opioid Systems Modeling Effort
TI - FDA Opioid Systems Modeling Effort
U1 - Grey Literature; Opioids & Substance Use
U4 - This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.
U5 - https://www.fda.gov/drugs/information-drug-class/fda-opioid-systems-modeling-effort
Y1 - 2022
ER -